PROPANC BIOPHARMA, INC. Other Current Liabilities
PROPANC BIOPHARMA, INC. (PPCB) had Other Current Liabilities of $29.78 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2023-05-15
- 2023-03-31: Other Liabilities, Current $29.78K.
- 2022-06-30: Other Liabilities, Current $30.75K.
| Period end | Other Liabilities, Current |
|---|---|
| 2023-03-31 | $29.78K 10-Q · filed 2023-05-15 |
| 2022-06-30 | $30.75K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |